Altium Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $3.78M | Buy |
6,958
+722
| +12% | +$392K | 0.27% | 50 |
|
|
2022
Q1 | $3.68M | Buy |
6,236
+533
| +9% | +$315K | 0.24% | 52 |
|
|
2021
Q4 | $3.81M | Buy |
5,703
+416
| +8% | +$278K | 0.25% | 50 |
|
|
2021
Q3 | $3.02M | Buy |
5,287
+64
| +1% | +$36.6K | 0.22% | 54 |
|
|
2021
Q2 | $2.64M | Buy |
5,223
+49
| +0.9% | +$24.7K | 0.19% | 59 |
|
|
2021
Q1 | $2.36M | Buy |
5,174
+254
| +5% | +$116K | 0.19% | 62 |
|
|
2020
Q4 | $2.29M | Buy |
4,920
+152
| +3% | +$70.8K | 0.2% | 56 |
|
|
2020
Q3 | $2.11M | Buy |
4,768
+120
| +3% | +$53K | 0.22% | 54 |
|
|
2020
Q2 | $1.68M | Buy |
4,648
+66
| +1% | +$23.9K | 0.19% | 62 |
|
|
2020
Q1 | $1.3M | Buy |
4,582
+1,243
| +37% | +$352K | 0.18% | 68 |
|
|
2019
Q4 | $1.09M | Buy |
3,339
+401
| +14% | +$130K | 0.13% | 90 |
|
|
2019
Q3 | $856K | Buy |
2,938
+154
| +6% | +$44.9K | 0.12% | 108 |
|
|
2019
Q2 | $818K | Sell |
2,784
-23
| -0.8% | -$6.76K | 0.12% | 108 |
|
|
2019
Q1 | $768K | Sell |
2,807
-61
| -2% | -$16.7K | 0.12% | 114 |
|
|
2018
Q4 | $642K | Buy |
2,868
+57
| +2% | +$12.8K | 0.12% | 121 |
|
|
2018
Q3 | $686K | Buy |
2,811
+89
| +3% | +$21.7K | 0.13% | 120 |
|
|
2018
Q2 | $564K | Buy |
+2,722
| New | +$564K | 0.15% | 106 |
|